Semax, An ACTH(4-10) Analogue with Nootropic Properties, Activates Dopaminergic and Serotoninergic Brain Systems in Rodents
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Corticotrophin (ACTH) and its analogues, particularly Semax (Met-Glu-His-Phe-Pro-Gly-Pro), demonstrate nootropic activity. Close functional and anatomical links have been established between melanocortinergic and monoaminergic brain systems. The aim of present work was to investigate the effects of Semax on neurochemical parameters of dopaminergic- and serotonergic systems in rodents. The tissue content of 5-hydroxyindoleacetic acid (5-HIAA) in the striatum was significantly increased (+25%) 2 h after Semax administration. The extracellular striatal level of 5-HIAA gradually increased up to 180% within 1-4 h after Semax (0.15 mg/kg, ip) administration. This peptide alone failed to alter the tissue and extracellular concentrations of dopamine and its metabolites. Semax injected 20 min prior D: -amphetamine dramatically enhanced the effects of the latter on the extracellular level of dopamine and on the locomotor activity of animals. Our results reveal the positive modulatory effect of Semax on the striatal serotonergic system and the ability of Semax to enhance both the striatal release of dopamine and locomotor behavior elicited by D-amphetamine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232 · cited 1×
“The clinical studies have also suggested that a decreased level of BDNF may be involved in the pathogenesis of the major depressive disorder (38,39).”
Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat
Kishi, T., Aschkenasi, C. J., Lee, C. E., Mountjoy, K. G., Saper, C. B., & Elmquist, J. K. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10454 · Cited by 581
Dopamine: a potential substrate for synaptic plasticity and memory mechanisms
Jay, T. M. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00085-6 · Cited by 577
Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537
Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.003 · Cited by 522
de Wied, D. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-122-31042 · Cited by 256
Clinical role of brain-derived neurotropic factor in mood disorders
Hashimoto, K. (2004) · Medical Entomology and Zoology · Cited by 183
Blöchl, A., & Sirrenberg, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21100 · Cited by 182
Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain
Garza, A. A., Ha, T., Garcia, C., Chen, M. J., & Russo‐Neustadt, A. A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.020 · Cited by 165
Narita, M., Aoki, K., Takagi, M., Yajima, Y., & Suzuki, T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00099-x · Cited by 164
Brain Melanocortin Receptors: From Cloning to Function
Adan, R. A. H., & Gispen, W. H. (1997) · Peptides · doi:10.1016/s0196-9781(97)00078-8 · Cited by 138
Goggi, J., Pullar, I. A., Carney, S. L., & Bradford, H. F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02505-2 · Cited by 134
Role of the mesotelencephalic dopamine system in learning and memory processes in the rat
Hefco, V., Yamada, K., Hefco, A., Hriţcu, L., Tiron, A., & Nabeshima, T. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02115-0 · Cited by 121
Chaki, S., Hirota, S., Funakoshi, T., Suzuki, Y., Suetake, S., Okubo, T., Ishii, T., Nakazato, A., & Okuyama, S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044826 · Cited by 117
The MC4 receptor mediates α-MSH induced release of nucleus accumbens dopamine
Lindblom, J., Opmane, B., Mutulis, F., Mutule, I., Petrovska, R., Klusa, V., Bergström, L., & Wikberg, J. E. S. (2001) · Neuroreport · doi:10.1097/00001756-200107200-00022 · Cited by 105
Melanocortins and the brain: from effects via receptors to drug targets
Adan, R. A. H., & Gispen, W. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00537-9 · Cited by 87
Witter, A., Greven, H. M., & Wied D, D. E. (1975) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30207-7 · Cited by 84
Signalling pathways involved in the short-term potentiation of dopamine release by BDNF
Goggi, J., Pullar, I. A., Carney, S. L., & Bradford, H. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02234-0 · Cited by 83
Neuropeptides: general characteristics and neuropharmaceutical potential in treating CNS disorders
Strand, F. L. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8049-7_1 · Cited by 73
Neuropeptides in learning and memory processes
de Wied, D. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)86050-0 · Cited by 63 · cited 3×
“influence of melanocortins on the central nervous system (3,6,7).”
Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors
Adan, R. A. H., Oosterom, J., Ludvigsdottir, G. K., Brakkee, J. H., Burbach, J. P. H., & Gispen, W. H. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90041-8 · Cited by 58
Shadrina, M. I., Dolotov, O. V., Grivennikov, I. A., Slominsky, P. A., Andreeva, L. A., Inozemtseva, L. S., Limborska, S. A., & Myasoedov, N. F. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01994-2 · Cited by 46 · cited 1×
“It has been previously reported that Semax increases expression of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in glial cell cultures in vitro (30) as well as the BDNF level in the basal forebrain ganglia and hippocampus of Wistar rats in vivo (11).”
Self-citationDown-regulation of the Trk-B signal pathway: the possible pathogenesis of major depression
Tsai, S. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00299-8 · Cited by 41
Barros, D. M., Izquierdo, L. A., Medina, J. H., et al. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482931 · Cited by 40
Entry of the synthetic ACTH(4–10) analogue into the rat brain following intravenous injection
Potaman, V. N., Antonova, L. V., Дубынин, В. А., Zaitzev, D. A., Kamensky, A. A., Myasoedov, N. F., & Nezavibat'ko, V. N. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90912-d · Cited by 38
Self-citationPeptide-induced grooming behavior and caudate nucleus dopamine release
Florijn, W. J., Holtmaat, A. J. D. G., de Lang, H., et al. (1993) · Brain Research · doi:10.1016/0006-8993(93)90151-c · Cited by 28
[A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].
Ip, A., Nezavibat'ko, V. N., Nf, M., et al. (1997) · PubMed · Cited by 28
Self-citationKawashima, N., Chaki, S., & Okuyama, S. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.024 · Cited by 27
Versteeg, D. H. G., Crom, M. P. G. D., & Mulder, A. H. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90600-4 · Cited by 24
The Heptapeptide SEMAX stimulates BDNF Expression in Different Areas of the Rat Brain in vivo
Dolotov, O. V., Seredenina, T. S., Levitskaya, N. G., Kamensky, A. A., Андреева, Л. А., Alfeeva, L. Y., Nagaev, I. Y., Zolotarev, Y. A., Grivennikov, I. A., Engele, Y., et al. (2003) · Doklady Biological Sciences · doi:10.1023/a:1025177812262 · Cited by 20
Self-citationDavid and Goliath — the slingshot that started the neuropeptide revolution
Strand, F. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00536-7 · Cited by 18
Florijn, W. J., de Boer, W. M., Tonnaer, J. A. D. M., et al. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10416-3 · Cited by 13
Recent developments in the psychopharmacology of social phobia
den Boer, J. A., van Vliet, I. M., & Westenberg, H. G. M. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190409 · Cited by 13
Effects of amphetamine and sydnocarb on dopamine release and free radical generation in rat striatum
Afanas'ev, I. I., Anderzhanova, E. A., Кудрин, В. С., & Rayevsky, K. S. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00574-3 · Cited by 12
Self-citationHorváth, K. M., Meerlo, P., Felszeghy, K., Nyakas, C. J., & Luiten, P. G. M. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00106-0 · Cited by 8
Effects of ACTH and ACTH 4?10 on aversive memory retrieval in rats
Kumar, K. B., & Karanth, K. S. (1995) · Journal of Neural Transmission · doi:10.1007/bf01271559 · Cited by 8
Anderzhanova, E. A., Rayevsky, K. S., Saransaari, P., & Oja, S. S. (2003) · Neurochemical Research · doi:10.1023/a:1024240814923 · Cited by 5
Self-citation(1996) · doi:10.1002/(sici)1520-6769(199609)19:2<115::aid-nrc171>3.0.co;2-b
Research works printed but not linked: 5
- A. Witter, 1975, J. Pharmacol. Exp. Ther., 193, 853
- F. L. Strand, 2003, Prog. Drug Res., 61, 1
- I. P. Asmarin, 1997, Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova, 47, 420
- I. P. Ashmarin, 1995, Neurosci. Res. Commun., 16, 105
- W. J. Florijn, 1992, J. Pharmacol. Exp. Ther., 263, 787
Cited by
An update on pharmacological approaches to neurodegenerative diseases
Scatena, R., Martorana, G. E., Bottoni, P., Botta, G., Pastore, P., & Giardina, B. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.59 · Cited by 66
“This corticotropin fragment afforded the improvement of neurochemical parameters of dopamine- and 5-HT-mediated systems, enhancing both the striatal release of dopamine and the locomotor behaviour with positive symptomatic effects in different neurodegenerative processes [96].”
BackgroundA New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides
Kolomin, T., Shadrina, M., Slominsky, P., Limborska, S., & Myasoedov, N. (2013) · Neuroscience and Medicine · doi:10.4236/nm.2013.44035 · Cited by 30
“A positive modulator effect of Semax on the serotoninergic system of the striatum was also shown [84], with reduction of nociception [85] and normalization of the circadian locomotor rhythms [86].”
Self-citationFilippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Sudarkina, O. Y., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., et al. (2020) · Genes · doi:10.3390/genes11060681 · Cited by 29
Self-citationLevitskaya, N. G., Vilensky, D. A., Sebentsova, E. A., Андреева, Л. А., Kamensky, A. A., & Myasoedov, N. F. (2010) · Biology Bulletin · doi:10.1134/s1062359010020147 · Cited by 21
Self-citationShadrina, M. I., Kolomin, T. A., Agapova, T. M., Agniullin, Y., Shram, S. I., Slominsky, P. A., Lymborska, S., & Myasoedov, N. F. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9270-z · Cited by 22
Self-citation
Metadata
- Authors
- Eremin, K. O., Kudrin, V. S., Saransaari, P., Oja, S. S., Grivennikov, I. A., Myasoedov, N. F., & Rayevsky, K. S.
- Affiliations
- University of Tampere (FI)
- Tampere University Hospital (FI)
- Institute of Molecular Genetics (RU)
- Institute of Pharmacology Russian Academy of Medical Sciences (RU)
- ORCID
- Grivennikov, Igor A.
- Venue
- Neurochemical Research
- Published
- 2005-12
- Volume
- 30
- Issue
- 12
- Pages
- 1493-1500
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W2016846216
- Cited by
- 29
- References
- 40
- Citations by year
- 2025: 5 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 1 · 2016: 3 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Semax, nootropic activity, dopaminergic system, serotonergic system, 5-hydroxyindoleacetic acid, striatum, dopamine release, d-amphetamine, locomotor activity, monoaminergic systems, extracellular neurotransmitter levels
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corpus Striatum, Dextroamphetamine, Dopamine, Hydroxyindoleacetic Acid, Male, Mice, Inbred C57BL, Motor Activity, Peptide Fragments, Serotonin Receptor Agonists, Dopamine Agonists, Nootropic Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.